Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04849273
Brief Title: A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC

First Submitted : April 12, 2021
First Submitted that Met QC Criteria : April 16, 2021
First Posted : April 19, 2021

Last Update Submitted that Met QC Criteria : November 19, 2021
Last Update Posted : November 22, 2021